The Motley Fool

Key Data Points

Primary metrics and data points about Alnylam Pharmaceuticals.
Current Price: $128.72
Prev Close: $129.62
Open: $129.22
Bid: $126.00
Ask: $135.00
Day's Range: $123.33 - $130.15
52wk Range: $52.35 - $140.00
Volume: 753,587
Avg Vol 756,619
Market Cap: $11B
P/E (ttm): -73.23
EPS (ttm): ($1.77)
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Alnylam Pharmaceuticals.

A biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating specific genes.

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers

Stock Charting

ALNY vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Alnylam Pharmaceuticals.
CAPS Rating 4 out of 5
 
371 Outperform
38 Underperform
CAPS All Stars
 
115 Outperform
12 Underperform

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

John M. Maraganore, CEO

84% Approve

Based on 6 Ratings

More Details for AlnylamJobs

Powered by

More Details about Alnylam Pharmaceuticals

Primary metrics and data points about Alnylam Pharmaceuticals.